文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

初始非脓毒症危重患者入院时血清25-羟基维生素D水平与结局

Serum Admission 25-Hydroxyvitamin D Levels and Outcomes in Initially Non-Septic Critically Ill Patients.
PubMed 文献 · Shock · 2018-01-01
一句话结论初始非脓毒症危重患者入院时25-羟基维生素D水平极低(<7 ng/mL)不预测脓毒症发生、院内死亡或ICU住院时间,但后续发生脓毒症者中该水平与呼吸道感染相关(OR 5.25)。

这项回顾性观察性队列研究纳入227例初始非脓毒症的危重患者,入ICU时测定25-羟基维生素D,并按水平分为严重低下组(<7 ng/mL,N=101)和≥7 ng/mL组(N=126),另设192例健康对照。危重患者入ICU时25-羟基维生素D水平远低于健康者(P<0.0001)。两组至脓毒症发生的中位时间、ICU住院天数及院内死亡率均相似。但在最终发生脓毒症的145例患者中,入院维生素D<7 ng/mL者发生呼吸道感染的OR为5.25(95%CI 1.5-18.32,P=0.009)。

要点

  • 危重患者入ICU时25-羟基维生素D水平远低于健康对照(P<0.0001)。
  • 严重低维生素D(<7 ng/mL)不预测脓毒症发生、院内死亡或ICU住院时间延长。
  • 在最终发生脓毒症的145例中,入院维生素D<7 ng/mL者呼吸道感染OR为5.25(95%CI 1.5-18.32,P=0.009)。
  • 两组至脓毒症发生的中位时间、ICU住院天数及院内死亡率均相似。

适用人群与场景

  • 初始非脓毒症的危重患者,收治于多学科ICU,入ICU时测定25-羟基维生素D。
  • 另设192例健康受试者作为对照。

诊断标准与关键阈值

  • 按入ICU时25-羟基维生素D水平分组:严重低下组<7 ng/mL(N=101),≥7 ng/mL组(N=126)。

研究设计与关键结果

  • 研究类型:回顾性观察性队列研究;样本量227例初始非脓毒症危重患者,另192例健康对照。
  • 危重患者入ICU时25-羟基维生素D水平远低于健康受试者(P<0.0001)。
  • 两组至脓毒症发生的中位时间无差异,ICU住院天数无差异,院内死亡率相似。
  • 在最终发生脓毒症的145例患者中,入院25-羟基维生素D<7 ng/mL者较≥7 ng/mL者发生呼吸道感染的OR为5.25(95%CI 1.5-18.32,P=0.009)。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于初始非脓毒症危重患者,入ICU时25-羟基维生素D<7 ng/mL不提示脓毒症发生风险、院内死亡风险或ICU住院时间增加。
  • 在最终发生脓毒症的患者中,入院25-羟基维生素D<7 ng/mL与呼吸道感染发生相关(OR 5.25,95%CI 1.5-18.32,P=0.009)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: To examine whether very low levels of 25-hydroxyvitamin D {25(OH)D} upon admission to the intensive care unit (ICU) are associated with worse outcomes.

METHODS: Retrospective observational cohort study of critically ill patients treated in a multidisciplinary ICU. Two hundred twenty seven initially non-septic, critically ill patients, in whom 25-hydroxyvitamin D was measured at ICU admission. An additional group of 192 healthy subjects was also used. Patients were categorized according to their vitamin D levels at admission; the two patient groups were those with severely low 25-hydroxyvitamin D levels (<7 ng/mL, N = 101) and those with vitamin D levels ≥7 ng/mL, N = 126.

RESULTS: ICU admission 25-hydroxyvitamin D levels of critically ill patients were much lower than those of healthy subjects (P < 0.0001). The median time to sepsis for the two patient groups did not differ, nor did the length of ICU stay (days). Both groups exhibited similar hospital mortality rates. However, among the fraction of patients who eventually became septic (N = 145), the odds ratio (OR) for developing respiratory infections in patients with admission vitamin levels < 7 ng/mL compared with patients with admission vitamin D levels ≥7 ng/mL was 5.25 {95% confidence interval (CI) 1.5-18.32, P = 0.009}.

CONCLUSIONS: Initially non-septic critically ill patients appear to have very low ICU admission 25-hydroxyvitamin D levels. Among critically ill patients, severely low vitamin D levels (<7 ng/mL) at ICU admission do not predict sepsis development, increased risk of in-hospital mortality, or longer stay in the ICU. However, these severely low admission vitamin D levels in patients who will eventually develop sepsis are associated with development of respiratory tract infections.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Vassiliou AG, Jahaj E, Mastora Z, et al. Serum Admission 25-Hydroxyvitamin D Levels and Outcomes in Initially Non-Septic Critically Ill Patients. Shock. 2018. PMID: 29337839. doi:10.1097/SHK.0000000000001105

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。